It is the short-cut for sure.
FDA dont usually suggest a Ph2b/3 right after Ph1b/2a, given the sample size of RAD101 trial history.
Sometimes they still require a complete Ph2 to test on patient in different doses.
- Forums
- ASX - By Stock
- Ann: FDA Pre-IND meeting supports an IND application for RAD 101
It is the short-cut for sure. FDA dont usually suggest a Ph2b/3...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAD (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.49M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.8¢ | $285.0K | 7.295M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1662188 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 5434 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1662188 | 0.037 |
4 | 294692 | 0.036 |
5 | 1118570 | 0.035 |
1 | 142000 | 0.034 |
1 | 100000 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 5434 | 1 |
0.039 | 335830 | 2 |
0.040 | 979281 | 5 |
0.041 | 615148 | 4 |
0.042 | 501257 | 2 |
Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
Featured News
RAD (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online